Conduct disorder: guidelines for investigating efficacy of pharmacological intervention.
Buitelaar
J K
JK
Montgomery
S A
SA
van Zwieten-Boot
B J
BJ
D000293:Adolescent; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002985:Clinical Protocols / Q000592:standards*; D015897:Comorbidity; D019955:Conduct Disorder / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D005260:Female; D006801:Humans; D038801:International Classification of Diseases / Q000592:standards; D008137:Longitudinal Studies; D008297:Male; D018579:Patient Selection; D012720:Severity of Illness Index; D016896:Treatment Outcome
D014150:Antipsychotic Agents